| 2025-12-04 |
详情>>
内部人交易：
HEARTY JAMES O共交易3笔
|
| 2025-10-29 |
详情>>
股本变动：
变动后总股本7060.00万股
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益6.77美元,归母净利润5.13亿美元,同比去年增长-24.29%
|
| 2025-10-29 |
财报披露：
美东时间 2025-10-29 盘后发布财报
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益4.67美元,归母净利润3.62亿美元,同比去年增长-21.65%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益2.05美元,归母净利润1.63亿美元,同比去年增长-32.02%
|
| 2025-04-24 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the nine director nominees, identified in the accompanying Proxy Statement, to the Board of Directors, each to serve until the Company's 2026 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025;
3.To approve, on an advisory basis, the compensation of our named executive officers.
|
| 2025-02-13 |
详情>>
业绩披露：
2022年年报每股收益6.03美元,归母净利润5.60亿美元,同比去年增长-42.73%
|
| 2025-02-13 |
详情>>
业绩披露：
2024年年报每股收益11.02美元,归母净利润9.36亿美元,同比去年增长35.40%
|
| 2024-10-29 |
详情>>
业绩披露：
2024年三季报(累计)每股收益7.86美元,归母净利润6.77亿美元,同比去年增长25.17%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益3.24美元,归母净利润2.94亿美元,同比去年增长-23.96%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益5.29美元,归母净利润4.62亿美元,同比去年增长57.13%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益2.73美元,归母净利润2.40亿美元,同比去年增长107.40%
|
| 2024-04-26 |
股东大会：
将于2024-06-06召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the ten director nominees, identified in the accompanying Proxy Statement, to the Board of Directors, each to serve until the Company's 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified.
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2024.
3.To approve, on an advisory basis, the compensation of our named executive officers.
|
| 2024-02-14 |
详情>>
业绩披露：
2023年年报每股收益7.62美元,归母净利润6.92亿美元,同比去年增长23.40%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益5.95美元,归母净利润5.41亿美元,同比去年增长9.87%
|
| 2023-04-25 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the nine director nominees, identified in the accompanying Proxy Statement, to the Board of Directors, each to serve until the Company's 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2023;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation;
5.To approve an amendment and restatement of the Company’s Restated Certificate of Incorporation to provide for the exculpation of officers as permitted by Delaware law.
|
| 2022-06-21 |
复牌提示：
2022-06-21 10:04:11 停牌，复牌日期 2022-06-21 10:09:42
|
| 2022-04-25 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the nine director nominees, identified in the accompanying Proxy Statement, to the Board of Directors, each to serve until the Company's 2023 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2022;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To consider and vote upon a stockholder proposal regarding political contributions disclosure, if properly presented at the Annual Meeting;
5.To transact such other business as may properly be brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-23 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the nine director nominees, identified in the accompanying Proxy Statement, to the Board of Directors, each to serve until the Company's 2022 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2021;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To consider and vote upon a stockholder proposal regarding political contributions disclosure, if properly presented at the Annual Meeting;
5.To transact such other business as may properly be brought before the Annual Meeting and any adjournment or postponement thereof by the presiding person of the Annual Meeting.
|
| 2020-04-27 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the eight director nominees identified in the accompanying Proxy Statement to the Board of Directors, each to serve until the Company's 2021 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2020;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve the DaVita Inc. 2020 Incentive Award Plan;
5.To consider and vote upon a stockholder proposal regarding political contributions disclosure, if properly presented at the Annual Meeting;
6.To transact such other business as may properly be brought before the Annual Meeting and any adjournment or postponement thereof by the presiding person of the Annual Meeting.
|
| 2019-12-06 |
股东大会：
将于2020-01-23召开股东大会
会议内容 ▼▲
- 1.For the approval of the amendment to the DaVita Healthcare Partners Inc. 2011 Incentive Award Plan (the "2011 Incentive Plan");
2.As determined by the proxy holders named in the proxy card in their discretion, with regard to all other matters as may properly be brought before the Special Meeting and any adjournment or postponement thereof by the presiding person of the Special Meeting.
|
| 2019-04-29 |
股东大会：
将于2019-06-17召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the eleven director nominees identified in the accompanying Proxy Statement to the Board of Directors to serve until the 2020 annual meeting of stockholders of the Company or until their successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2019;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2018-04-27 |
股东大会：
将于2018-06-18召开股东大会
会议内容 ▼▲
- 1.To vote upon the election of the ten director nominees identified in the attached Proxy Statement to the Board of Directors to serve until the 2019 annual meeting of stockholders of the Company or until their successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2018;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To consider and vote upon a stockholder proposal regarding revisions to the Company's proxy access bylaw, if properly presented at the meeting;
5.To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-05-01 |
股东大会：
将于2017-06-16召开股东大会
会议内容 ▼▲
- 1. To vote upon the election of the eleven director nominees identified in the attached Proxy Statement to the Board of Directors to serve until the 2018 annual meeting of stockholders of the Company or until their successors are duly elected and qualified;
2. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2017;
3. To hold an advisory vote to approve executive compensation;
4. To hold an advisory vote on the frequency with which future advisory votes on executive compensation should be held;
5. To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2016-05-10 |
股东大会：
将于2016-06-20召开股东大会
会议内容 ▼▲
- 1. To vote upon the election of the ten director nominees identified in the attached Proxy Statement to the Board of Directors to serve until the 2017 annual meeting of stockholders of the Company or until their successors are duly elected and qualified;
2. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2016;
3. To hold an advisory vote to approve executive compensation;
4. To adopt and approve proposed amendments to our Amended and Restated Bylaws to adopt proxy access;
5. To adopt and approve an amendment to increase the number of shares available under our Employee Stock Purchase Plan by 7,500,000 shares;
6. To consider and vote upon a stockholder proposal regarding action by written consent, if properly presented at the annual meeting;
7. To transact such other business as may properly come before the annual meeting or any adjournment thereof.
|
| 2015-04-30 |
股东大会：
将于2015-06-16召开股东大会
会议内容 ▼▲
- 1. To vote upon the election of the nine directors identified in the attached Proxy Statement to the Board of Directors to serve for a term of one year or until their successors are duly elected and qualified;
2. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2014;
3. To hold an advisory vote on executive compensation;
4. To consider and vote upon a stockholder proposal, if properly presented at the annual meeting;
5. To transact such other business as may properly come before the annual meeting or any adjournment thereof.
|